ripekg:evaluation/RIPEAA805A88D874EA69C |
prov:used |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAA805A88D874EA69C |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAA805A88D874EA69C |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripe:concerns |
ripekg:work/10.1007%2Fs13318-014-0242-5The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripe:recruitmentEndDateExtractionRationale |
No recruitment finish date found in the text. |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripe:recruitmentStartDateExtractionRationale |
No recruitment start date found in the text. |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
ripe:studyEndDateExtractionRationale |
No study end date found in the text. |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-2-2 |
ripekg:study-design-evidence/RIPEAA805A88D874EA69C |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-inspectai-2-2 |